A. List of Publications
i. Publications until the last promotion
Reviewed Articles:
Basic Research
1. Kraiem Z., Shasha S.M., Ben Aryeh H., Glasser B., Scheinfeld M., Kristal B., Chirorg S.,
Do cyclic AMP concentration in saliva reflect PTH biologic activity? Metabolism 1985;34: 505-8.
IF 2.588, 56/105 Endocrinology & Metabolism, Contribution A,B,C
2. Shasha S.M., Kristal B., Barizilai M., Mokov V.E., Shkolnik T. In vitro effect of PTH on normal T cell functions. Nephron 1988;50:212-6.
IF 2.012, 31/62 Urology & Nephrology, Contribution A,B,C
3. Shasha S.M., Kristal B., Karkaby L., Chazer J., Manaster J., Shkolnik T. The effect of calcium channel blockers on osmotic fragility of Erythrocytes of uremic and hypertensive patients. Curr. Therap. Res. 1988;44:72-7.
IF 0.238, 89/91 Medicine, Research & Experimental, Contribution A,C,D
4. Shasha S.M., Kristal B., Steinberg O., Shkolnik T. Effect of parathyroidectomy on T cell Functions in patients with primary hyperparathyroidism. Am. J. Nephrol. 1989;9:25-9.
IF 3.481, 11/62 Urology & Nephrology, Contribution A,B,C,D
5. Shasha S.M., Nusam D., Labin L., Kristal B., Steinberger O., Barzilai M., Shkolnik T. Effect of converting enzyme inhibitor captopril on T cell functions in essential hypertension. Nephron. 1991;59:586-90.
IF 2.012, 31/62 Urology & Nephrology, Contribution A,C
6. Shasha S.M. Shasha U., Kristal B., Barizilai M., Steinberger O., Shkolnick T. Proliferative response of T-lymphocytes to mitogenic lectins in essential hypertension. Nephron. 1991;58:413-7.
IF 2.012, 31/62 Urology & Nephrology, Contribution A,C
7. Gerez L., Madar L., Shkolnik T., Kristal B., Arad B., Reshef R., Steinberger A., Ketzniek M., Sayar D., Shasha S.M., Kaempfer R. Regulation of interleukin – 2 and gamma interferon on gene expression in renal failure. Kidney Int. 1991;40:266-72.
IF 6.193, 3/62 Urology & Nephrology, Contribution A,D
8. Sela S., Shasha S.M., Mashiach E., Haj M., Kristal B., Shkolnik T. Effect of oxygen tension on activity of antioxidant enzymes and renal function of post ischemic reperfused rat kidney. Nephron. 1993;63:199-206.
IF 2.012, 31/62 Urology & Nephrology, Contribution A,D
9. King R. T., Kristal B., Myers B.D. The biophysical basis of hypofiltration in nephrotic humans with membranous nephropathy. Kidney Int. 1994;45:390-7.
IF 6.193, 3/62 Urology & Nephrology, Contribution A,B,C,D
10. Drumond M.C., Kristal B., Myers B.D., Deen W.D. Structural basis for reduced glomerular filtration capacity in nephrotic humans. J Clin Invest 1994;94:1187-95.
IF 15.387, 2/91 Medicine, Research & Experimental , Contribution A,B,C,D
11. Shurtz-Swirski R., Shasha S.M., Kristal B., Mashiach E., Shkolnik T. Antioxidant enzymes activity in polymorphonuclear leukocytes in renal failure. Nephron1995;
71:176-9.
IF 2.012, 31/62 Urology & Nephrology, Contribution A,D
12. Shurtz-Swirski R., Kristal B., Shkolnik T., Weissman I., Shapiro G. and Shasha S.M. The short-term effect of erythropoietin on T cell mitogenic proliferation in CRF patients. Nephron 1996;72:27-9.
IF 2.012, 31/62 Urology & Nephrology, Contribution A,D
13. Manaster J., Chezar J., Shurtz-Swirski R., Shapiro G., Tendler Y., Kristal B., Shasha S.M. and Sela S. Heparin induces apoptosis in human peripheral blood neutrophils. Br. J. Haematol 1996;94:48-52.
IF 4.597, 13/61 Hematology, Contribution A,B,C,D
14. Kristal B., Shurtz-Swirski R., Chezar J., Manaster J., Tendler Y., Levy R., Shapiro G., Weissman I., Shasha S.M., Sela S. Participation of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in patients with essential hypertension. Am J Hypertens 1998;11:921-8.
IF 3.122, 19/56 Peripheral Vascular Diseases, Contribution A,B,C,D
15. Mashiach E., Sela S., Winaver J., Shasha S.M., Kristal B. Renal ischemic reperfusion:
Contribution of nitric oxide and renal blood flow. Nephron 1998;80:458-67.
IF 2.012, 31/62 Urology & Nephrology, Contribution C,D
16. Squarer A., Lemley. K.V., Ambalavanan S., Kristal B., Deen W.M., Sibley R., Anderson L., Myers B. D. Mechanisms of progressive glomerular injury in membranous nephropathy. J Am Soc Nephrol 1998;9:1389-98.
IF 7.689, 1/62 Urology & Nephrology, Contribution A,B,C,D
17. Kristal B., Shurtz-Swirski, R., Furmanov M., Weissman I., Hassan K., Shasha, S.M., Manaster, J., Sela, S. Interaction between erythropoietin and peripheral polymorphonuclear leukocytes in hemodialysis patients. Nephron 1999; 81:406-13.
IF 2.012, 31/62 Urology & Nephrology, Contribution A,B,C,D
18. Mashiach E., Sela S., Cohen H.I., Shasha S.M., Weinstein T., Kristal B. Mesna: a new renoprotective antioxidant in ischemic acute renal failure. Nephrol Dial Trans 2001;16:542-51.
IF 3.306, 13/62 Urology +Nephr, Contribution A,C,D
19. Sela S., Shurtz-Swirski R., Hamzi M., Shapiro G., Shasha S.M., Kristal B. Oxidative stress during hemodialysis: effect of heparin. Kidney Int. 2001;59,S159-S163.
IF 6.193, 3/62 Urology +Nephr, Contribution A,C,D
20. Shurtz-Swirski R., Sela S., Herskovits A.T., Shasha S.M., Shapiro G., Nasser L., Kristal B. The involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients. Diabetes Care 2001;24:104-10.
IF 7.349, 5/93 Endocrinology+metabolism, Contribution A,C,D
21. Sela S., Shurtz-Swirski R., Sharon R., Manaster J., Chezar J., Shkolnik G., Shapiro G., Shasha S.M., Merchav S. Kristal B. The polymorphonuclear leukocyte – a new target for erythropoietin. Nephron 2001;88:205-10.
IF 2.012, 31/62 Urology & Nephrology, Contribution A,C,D
22. Sela S., Shurtz-Swirski R., Farah R., Levy R., Shapiro G., Chezar J., Shasha S.M. Kristal B. A link between polymorphonuclear leukocyte intracellular calcium, plasma insulin and essential hypertension. American Journal of Hypertension 2002;15(4):291-5.
IF 3.122, 19/56 Peripheral Vascular Diseases, Contribution A,C,D
23. Shurtz-Swirski R., Kristal B., Shasha S.M., Shapiro G., Geron R., and Sela S. Interaction between erythropoietin and peripheral polymorphonuclear leukocytes in continuous ambulatory dialysis patients. Nephron 2002;91(4):759-61.
IF 2.012, 31/62 Urology & Nephrology, Contribution A,C,D
24. Sela S., Shurtz-Swirski R., Awad J., Shapiro G., Nasser L., Shasha S.M., Kristal B. The Involvement of Peripheral Polymorphonuclear Leukocytes in the Oxidative Stress and Inflammation in Cigarette Smokers. The Israel Medical Association Journal 2002;11(4):1015-9.
IF 0.898, 80/132 Medicine, General+Internal, Contribution A,C,D
25. Michelis R., Gery R., Sela S., Shurtz-Swirski R., Grinberg N., Snitkovski T., Shasha S.M., Kristal B. Carbonyl fibrinogen, a new marker of severe oxidation, is enhanced by intravenous iron hazards – protein oxidation during hemodialysis session. Nephrology Dialysis Transplantation 2003;18:924-30.
IF 3.306, 13/62 Urology +Nephr, Contribution A,C,D
26. Shusterman T., Sela S., Cohen H., Kristal B., Sbeit W., Reshef R. The effect of the antioxidant Mesna (2- mercapto-ethane sulfonate) on experimental colitis. Digestive Diseases and Sciences 2003;Jun 48(6):1177-85.
IF 1.583, 38/55 Gastroenterol+Hepatol, Contribution A,D
27. Sela S., Mazor R., Amsalam M., Yagil C., Yagil Y. and Kristal B. Primed polymorphonuclear leukocytes, oxidative stress and inflammation precede the rise in blood pressure in a DOCA-salt induced hypertension. Hypertension 2004;44:764-9.
IF 7.368, 3/56 Peripheral Vascular Diseases, Contribution A,C,D
28. Burbea Z, Nakhoul F, Zoabi R, Hochberg I, Levy NS, Benchetrit S, Weissgarten J, Tovbin D, Knecht A, Iaina A, Herman M, Kristal B, Levy AP. Haptoglobin phenotype as a predictive factor of mortality in diabetic haemodialysis patients. Ann Clin Biochem. 2004;Nov;41(Pt 6):469-73.
IF 1.917, 9/28 Medicine, Laboratory & Technological, Contribution B
i. Clinical Descriptive Research:
29. Kristal B., Shasha S.M., Heg M, Stamler B. Management of uremic pericarditis. Israel J. Med. Sci. 1986;22:442-4
IF 0.898, 80/132 Medicine General, Contribution A,B,C,D
30. Kristal B., Shasha S.M., Labin L., Cohen A. Estimation of quantitative proteinuria by using the protein creatinine ratio in random urine samples. Am. J. Nephrol. 1988;8:198-203.
IF 3.481, 11/62, Urology & Nephrology, Contribution A,B,C,D
31. Grushka E., Garty Y., Kristal B., Goldhammer E., Abineder E.G., Shasha S.M. Cardiac arrhythmia in chronic renal failure by holter monitoring during hemodialysis and intermittent peritoneal dialysis. Isr. J. Med. Sci. 1990;26:378-82.
IF 0.898, 80/132 Medicine, General & Internal, Contribution C,D
32. Shasha S.M., Kamal H., Kristal B., Galetzky G., Rougin N., Shkolnik T. Red cell filterability in cigarette smokers and its relations to cardiac hypertrophy. Atherosclerosis 1993;98:91-8.
IF 4.522, 9/60, Peripheral Vascular Disease, Contribution C,D
33. Hassan K., Simri W., Rubinchik I., Manelis J., Gross B., Shasha S.M., Kristal B. The
effect of erythropoietin therapy on polyneuropathy in predialytic patients. J Nephrol 2003;16(1):121-5.
IF 1.252, 44/62, Urology & Nephrology, Contribution A,C,D
34. Hassan K., Shternberg L., Alhaj M., Giron R., Reshef R., Barak M., Kristal B. The effect of erythropoietin therapy and hemoglobin levels on the immune response to Engerix-B vaccination in chronic kidney disease. Renal Failure 2003;25(3):471-8.
IF 0.840 52/62 Urology & Nephrology, Contribution A,C,D
35. Hassan K., Amir S., Michael S., Simri W., Haj M., Shasha, S.M., Kristal B. Electrophysiological abnormalities in upper extremities after brachiocephalic A-V fistulas construction in predialysis patients. Renal Failure 2004; 26(2):111-7.
IF 0.840, 52/62 Urology & Nephrology, Contribution A,C,D
36. Kamal H., Gross B., Simri W, Rubinchik I., Cohen H.I., Jacobi J., Shasha, S.M., Kristal B. The presence of erythropoietin receptors in the human peripheral nervous system. Clin Nephrology 2004;61(2):127-129.
IF 1.373, 43/62 Urology & Nephrology, Contribution A,B,C,D
Case Reports:
37. Shasha S.M., Kristal B., Chetbaum I., Roguin N., Zveibil F. Acute pericardial tamponade secondary to subclavian catheter for Dialysis. Dial. Transplant. 1988;17:229-300.
IF 0.184, 60/62 Urology & Nephrology, Contribution A,C,D
38. Heg M., Kristal B., Shasha S.M. Delayed laceration of intestinal wall by the permament Tenckhoff peritoneal catheter. Perit. Dial. Intern. 1988;8:25-6.
IF 1.636, 40/62 Urology & Nephrology, Contribution C,D
39. Hassan K., Weisman I., Osman S., Gery R., Oettinger M., Shasha S.M., Kristal B. Successful pregnancy in a patient with polycystic kidney disease and advanced renal failure without prophylactic dialysis. Nephron 2001;87, 85-8.
IF 2.012, 31/62 Urology & Nephrology, Contribution A,D
40. Hassan K., Farah R., Hamzi H., Cohen H.I., Kristal B. Unusual presentation of rectal adenocarcinoma. Rom J Gastroenterol 2003;12(1):47-50.
IF 1.265, 51/66 Gastroenterology & Hepatology, Contribution A
41. Farah R., Makhoul, N., Kristal, B. Amanita phalloidal causing acute renal failure and liver disease resolved with intensive therapy. Clinical Intensive Care 2003;14(3):105-7. Contribution A , D
ii. Publications since last promotion
Reviewed Articles:
Basic Research:42. Sela, S., Shurtz-Swirski, R., Cohen-Mazor, M., Mazor, R., Chezar J., Shapiro, G., Hassan, K., Shkolnik, G., Geron R., Kristal, B. The Primed Peripheral Polymorphonuclear Leukocyte - a Culprit Underlying Chronic Low-Grade Inflammation and Systemic Oxidative Stress in Chronic Kidney Disease. J Am Soc Nephrol 2005;6(8):2431-8.
IF 7.505, 1/57 Urology +Nephr, Contribution A,C,D
43. Michelis R, Sela S., Kristal B. Intravenous iron-gluconate during hemodialysis modifies plasma β2-microglobulin properties and levels. Nephrology Dialysis Transplantation 2005;20:1963-9.
IF 3.306, 13/62 Urology +Nephr, Contribution A,C,D
44. Jacobi J., Kristal B., Chezar J., Shasha S.M., Sela S. Exogenous superoxide mediates pro-oxidative, pro-inflammatory and procoagulatory changes in primary endothelial cell cultures. Free Radic Biol Med. 2005;Nov 1;39(9):1238-48.
IF 5.399, 43/271 Biochem+Molecular Biol, Contribution A,D
45. Jacobi J., Sela S, Cohen H.I., Chezar J., Kristal B. Priming of polymorphonuclear leukocytes -a culprit in the initiation of endothelial cell injury. Am J Physiol Heart Circ Physiol. 2006;May 290(5):H2051-8.
IF 3.712, 12/60 Perioheral Vascular Diseases, Contribution A,B,C,D
46. Geron R., Shurtz-Swirski R., Sela S., Gurevitch Y., Tanasjtchouk T., Shkolnik G., Tanhilevski O., Kristal B. Polymorphonuclear leukocyte priming in long intermittent nocturnal hemodialysis patients – is melatonin a player? Nephrology Dialysis Transplantation 2006;21:3196-201.
IF 3.306, 13/551Urology+ Nephr, Contribution C,D
47. Mazor R., Shurtz –Swirski R. , Sela S. , Shapiro G., Kristal B. Polymorphonuclear leukocyte priming and counts are in correlation with blood pressure parameters. Harefuah 2006:Dec 145:900-3.
Contribution A,D
48. Shurtz-Swirski R. , Farah R. , Sela S. , Shapiro G. , Klempef R., Snitkovski T., Kristal B. The effect of calcium channel blocker Lercanidipine on low-grade inflammation parameters in essential hypertension patients. Harefuah 2006;Dec 145:895-9.
Contribution A,D
49. Mazor R. , Kristal B., Cohen- Mazor M., Yagil C., Yagil Y. and Sela S. The Polymorphonuclear Leukocyte Contributes to the Development of Hypertension in the Sabra Rat. J Hypertens. 2007 Nov;25(11):2249-2256.
IF 5.132, 9/56 Peripheral Vascular Diseases, Contribution A,D
50. Mazor R., Shurtz-Swirski R., Farah R., Kristal B., Shapiro G., Dorlechter F., Cohen-Mazor M., Meilin E, Snitkovski T., Sela S. Primed Polymorphonuclear Leukocytes Constitute a Possible Link Between Inflammation and Oxidative Stress in Hyperlipidemic Patients. Atherosclerosis 2008 Apr;197(2):937-43.
IF 4.522, 9/60 Peripheral Vascular Diseases, Contribution D
51. Kristal B., Shurtz-Swirski R., Tanhilevski O., Shapiro G., Shkolnik G., Chezar J., Snitkovski T., Cohen-Mazor M., Sela S. Epoetin-alpha may preserve kidney function via attenuation of polymorphonuclear leukocyte priming. Israel Medical Association Journal, 2008 April;10;4:266-272
IF 0.898, 80/132 Medicine, General & Internal, Contribution A,C,D
52. Cohen-Mazor M., Sela S., Mazor R., Ilan N., Vlodavski I., Rops AL., Van der Vlag J., Cohen HI., Kristal B. Are primed polymorphonuclear contributors to the high hepoaranase levels in hemodialysis patients? Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H651-8.
IF 3.712, 12/60 Peripheral Vascular Diseases, Contribution A,D
53. Meilin E., Sela S., Kristal B., Heparin cryo-precipitation reduces levels of non-traditional risk factors for atherosclerosis in-vitro. Blood Purification, 2008 March 5; 26:238-248.
IF 1.893, 34/62 Urology +Nephr, Contribution A,C,D
54. Gabrielli D., Kristal B., Katzarski K., Yousser M., Hachache T., Lopot F., Lasseur C., Gunne T., Draganov B., Wojke R., Gauly A. Improved intadialytic stability during haemodialysis with blood volume controlled ultrafiltration, Journal of Nephrology, 2009 Mar-Apr;22(2):232-40.
IF 1.252, 44/62, Urology & Nephrology, Contribution B,D
55. Mazor R., Itzhaki O., Sela S., Yagil Y., Cohen-Mazor M., Yagil C., Kristal B. TNF- á: a Possible Priming Agent for the PMNL NADPH Oxidase in Hypertension, Hypertension , Feb 2010; 55:353-362
IF 7.368, 3/56 Peripheral Vascular Diseases, Contribution A,D
56. R. Michelis, B. Kristal, T Snitkovsky. S. Sela., Oxidative modifications impair albumin quantifications. Biochemical and Biophysical Research Communications, 2010; 401:137-142.
IF 2.648, 134/271 Biochem+Molecular Biol, Contribution A,D
57. Sela S. , Michelis R., Kristal B., Are oxidative modifications of proteins a metabolomic signature of cardio vascular disease in CKD ? American J. of Kidney Dis., accepted.
IF 5.434 , 6/73 (Urology & Nephrology), Contribution A,D
Clinical Descriptive Research:
58. Kamal H., Rogiun N., Kagan O., Kristal B. Effect of erythropoietin on red cells filterability and left ventricular mass in predialysis patients. Renal Failure 2005:27(2).
IF 0.840, 52/62, Urology & Nephrology, Contribution A,D
59. Geron R., Tanchilevski O., Kristal B. Catheter Lock solution-TaurolockTM for prevention of catheter – related bacteremia in hemodialysis patients. Harefuah 2006; Dec 145:881-4.